Previous Article | Next Article 
Journal of Virology, May 1999, p. 3616-3622, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Enrichment of a Precore-Minus Mutant of Duck
Hepatitis B Virus in Experimental Mixed Infections
Yong-Yuan
Zhang and
Jesse
Summers*
Department of Molecular Genetics and
Microbiology, The University of New Mexico School of Medicine,
Albuquerque, New Mexico 87131
Received 25 November 1998/Accepted 27 January 1999
 |
ABSTRACT |
A precore-deficient mutant of duck hepatitis B virus (DHBV)
produced by site-directed mutagenesis was tested for its ability to
compete with wild-type virus in a mixed infection of 3-day-old ducklings. The mutation was shown to produce a cis-acting
defect, resulting in a replication rate that was about one-half that of wild-type virus. Accordingly, wild-type virus was rapidly selected during the spread of infection. During the chronic phase of the infection, however, two selection patterns were seen. In 4 of 10 ducks,
the wild-type virus slowly replaced the precore mutant. In another four
ducks, the precore mutant virus slowly replaced the wild-type virus. In
the remaining two ducklings, ratios of wild-type and precore mutant
virus fluctuated, with wild-type virus slowly predominating. The
replacement of wild-type virus was not due to the emergence of a
rapidly replicating variant of the precore mutant, since genomes cloned
from the infected ducks retained their original replication defect.
Replacement of wild-type virus, however, correlated with elevated
anti-core antibody titers, which continued to increase with time. The
selection of a precore-negative strain of DHBV may be analogous to the
selection for precore mutants of HBV during chronic hepatitis in humans.
 |
INTRODUCTION |
Hepadnaviruses are a small group of
DNA viruses that replicate their genomes through reverse transcription
of an RNA intermediate (9, 23, 35, 38). These viruses have
been found in humans (6, 32, 39), woodchucks and ground
squirrels (22, 41, 42), and several species of waterfowl,
including ducks (24, 36). All hepadnaviruses share similar
genetic structures consisting of the three genetic regions essential
for replication, i.e., the core, P protein, and envelope regions
(reviewed in references 7, 29). In addition to these
three genetic regions, the mammalian hepadnaviruses contain a fourth
gene, commonly called the X gene, whose function in replication has not
been clearly defined (45). The core regions of all known
hepadnaviruses can be divided into two functional units that encode two
overlapping protein products in the same reading frame (21).
One product, the capsid protein, is a viral structural protein
essential for RNA packaging, reverse transcription, and virus assembly.
The second product, the precore protein, is a nonstructural protein
translated from an mRNA that contains an upstream in-frame AUG
followed by a small number of codons that encode a type I signal
recognition sequence. The precore protein is translocated into the
endoplasmic reticulum as it is translated, where the signal recognition
sequence is cleaved and the basic C terminus of the protein is
proteolytically removed. Subsequent to this processing, the precore
protein is transported through the Golgi apparatus and secreted from
the cell (10, 37). Processed precore protein is found in the
blood of animals with chronic hepadnavirus infections and is called
"e antigen" (20). The e antigen has long been a
convenient serological marker associated with high levels of viremia in
hepatitis B virus (HBV)-infected humans (44).
Stop codons engineered into the precore open reading frame of duck HBV
(DHBV) or woodchuck hepatitis virus (WHV) do not inhibit virus
replication or prevent infection (34), although
precore-negative WHV mutants have been reported to produce only
transient infection of woodchucks (4). Moreover, spontaneous
precore-negative mutants arise commonly in chronic HBV or WHV
infections and can emerge as the predominant genotype (2, 3, 19,
31, 43). The basis for selection of precore mutants in chronic
hepadnavirus infection is not known. Published evidence implicates the
precore protein in HBV as a regulator of replication (1, 28, 30, 33), but in DHBV, no increase in replication rate has been
observed in engineered precore mutants (44a).
It has been proposed that the precore protein functions through the
production of extracellular e antigen to modulate the T-cell response
to core antigen. This effect was demonstrated for one core antigen-e
antigen T-cell epitope in e antigen- and core antigen-producing
transgenic mice (25-27). By several assays, the presence of
e antigen caused a reduction or elimination of the Th1-dependent
immunoglobulin G2 (IgG2) anti-core antibody response in e
antigen-transgenic mice in favor of a Th2-dependent IgG1 antibody
response. Since Th1 response is thought to be important in virus
clearance, it was proposed that the suppression of this response might
favor chronic infections and produce an overall benefit for the virus
in the efficiency of viral transmission. However, e antigen may also
target cells for T-cell killing in the presence of an effective T-cell
response, resulting in the selection of e antigen-negative virus mutants.
The experiments we report here were undertaken to examine selection of
DHBV variants during a chronic infection. We carried out a mixed
infection of ducklings with wild-type virus and a precore-defective
mutant DHBV with a weak replication defect. We found that after an
initial expected wild-type enrichment during the spread of infection,
the wild-type virus was unexpectedly eliminated in favor of the precore
mutant in some birds. This results suggests that the phenotype of a
precore DHBV mutant may confer a selective advantage under some
conditions during chronic infection, resulting in the selection of
precore-minus mutants, as has been observed with HBV.
 |
MATERIALS AND METHODS |
Animals.
One-day-old ducklings were obtained from Metzer
Farms (Redlands, Calif.), and congenitally infected birds were
identified by dot hybridization. Only virus-free birds were used in the experiments.
Plasmids and mutants.
Viral genomes were cloned as
head-to-tail dimers in plasmid pSP65. The wild-type DHBV used in this
study was DHBV 16 (19). The mutant DHBV 16, called 2619A,
was kindly provided by Wengang Yang. This mutant contained a
single-nucleotide substitution of A for T at nucleotide position 2619, which created a stop codon, TGA, at position 34 in the precore open
reading frame. The nucleotide substitution also caused a
cis-acting replication defect that reduced the replication
rate of this mutant by about 40% (44a) (see below).
Transfections and production of virus inocula.
Production
and concentration of infectious virus after transfection of LMH cells
was performed as previously described (15, 40). Enveloped
virus concentrations were determined by selective extraction of viral
DNA from virus preparations, by agarose gel electrophoresis, and by
Southern blot hybridization. Virus was concentrated by polyethylene
glycol precipitation as previously described (16). Viral DNA
was determined by comparison of the hybridization signal with that
obtained from known amounts of cloned viral DNA run in the same gel.
Procedures used in the analysis of viral DNA replicative intermediates,
agarose gel electrophoresis, and blot hybridization were previously
published (40).
Analysis of viral DNA in the serum.
The level of viremia was
determined by quantitation of viral DNA in the serum by dot
hybridization and phosphorimage analysis. Serum (2 µl) was applied
directly to nylon membranes, denatured by brief treatment with alkali,
and neutralized with 0.2 M Trizma HCl. DNA was detected on the filter
by hybridization with a riboprobe specific for the minus strand, as
previously described. For analysis of the viral genotype, serum (10 µl) was mixed with 10 µl of 0.2 N NaOH and incubated for 1 h
at 37°C to disrupt the virus and denature the viral DNA. The samples
were neutralized by the addition of 10 µl of 0.2 N HCl, cleared by
brief microcentrifugation, and diluted with the addition of 30 µl of
TE (10 mM Tris-HCl, pH 7.5, 1 mM EDTA). Five microliters of the sample
was then used in a 50-µl PCR mixture.
PCR and sequencing.
Amplification of the serum viral DNA was
carried out with a primer set corresponding to nucleotides 2548 to 2571 (biotinylated plus strand) and 2840 to 2818 (minus strand). The
standard PCR buffer contained DNA template; 200 µM (each) dATP, dGTP,
dCTP, and TTP; 50 mM KCl; 10 mM Tris-HCl, pH 8.3; 1.5 mM
MgCl2; 0.02% gelatin; and 38 pmol of each primer in a
final volume of 50 µl, with 2.5 U of Taq DNA polymerase
(Sigma). Amplification was carried out for 35 cycles of 94°C for
30 s, 58°C for 30 s, and 72°C for 45 s. The
biotinylated PCR products (40 µl) were adsorbed with 20 µl of
strepavidin-coated M-280 Dynabeads (Dynal Corp.) suspended in a
solution of 20 mM Tris-HCl (pH 8.0)-2 M NaCl-1 mM EDTA, and washed
two times with 50 µl of TE with the help of a magnetic particle
concentrator (catalog no. 120.04; Dynal). The nonbiotinylated strand
was released from the beads by denaturation in 0.1 N NaOH (50 µl),
the denaturing solution was removed, and the beads were washed two
times with 50 µl of TE. Washed beads with specifically bound
biotinylated plus-strand products were used directly in sequencing
reactions with a minus-strand primer (nucleotides 2747 to 2729).
Quantitation of viral genotypes.
Sequencing gels were used
to determine the ratio of the two genotypes in the samples of amplified
DNAs. In order to evaluate this assay, we performed an experiment using
known ratios of plasmids containing the two genomes, 2619A and wild
type (2619T). Plasmid mixtures (50 pg) containing 0, 20, 50, 80, and
100% wild type were amplified, and the plus strand was sequenced with
a minus-strand primer as described above. The A bands (wild-type minus
strand) and the T bands (mutant minus strand) at position 2619 were
quantitated by phosphorimaging and normalized to the intensity of the
corresponding immediately preceding A or T band in the respective lanes
of the sequencing gel. This normalization corrected for variations in the amount of radioactivity loaded in each lane. Each corrected value
was then normalized to the sum of the two corrected values to determine
the fraction of the ladder that was due to either mutant or wild-type
sequences, assuming that at position 2619 only two genotypes existed.
Three examples of these experimentally determined values were plotted
against the standard ratios in the templates and are shown in Fig.
1. Standardization curves thus obtained
showed a direct relationship between the fraction of a genotype in the
template and the experimentally determined ratio of the wild-type and
mutant residues at position 2619. For all the data presented in this
paper, standardization curves were used to determine the ratio of
wild-type genomes to mutant genomes in the PCR templates.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 1.
PCR sequencing assay for serum virus genotype. DNAs (50 pg total) consisting of the indicated ratios of wild type (WT) to
mutant 2619A dimer plasmids were linearized by digestion with the
single-cut enzyme SalI and subjected to PCR amplification.
The plus strand, containing the biotinylated primer, was isolated, and
two sequencing reactions were performed with dideoxyadenosine
triphosphate (lanes A) for detection of the wild-type 2619T residue in
the plus strand and with dideoxythymidine triphosphate (lanes T) for
detection of the 2619A residue. The signals in the A lanes and the T
lanes at position 2619 were corrected for loading and normalized, and
the fraction of the wild-type signal was plotted against the fraction
of wild-type plasmid DNA in the template. The results of separate
loadings of a single pair of reactions are shown. The curve was
calculated by linear regression analysis.
|
|
Enzyme-linked immunosorbent assay for antibody to core
antigen.
Assays for antibody to core antigen were performed in
96-well microtiter plates coated with recombinant DHBV core protein produced in Escherichia coli. The wells were incubated with
100 ng of core protein, blocked, and incubated with samples diluted serially 1:5, starting with a 1:100 dilution, for 1 h at 37°C. Bound duck Ig was detected by incubation with horseradish
peroxidase-conjugated rabbit anti-duck IgG (heavy plus light chains)
(Nordic Immunology, Tilberg, The Netherlands) diluted 1:10,000 and by
reaction with the color reagent o-phenylenediamine. One unit
was defined as the reciprocal of the dilution that produced an optical
density at 495 nm of 0.5. The titers (see Fig. 4B) were normalized to a
standard serum sample run with every set of assays. The standard serum
value was between 2,600 and 19,000 U per ml in different assays.
PCR amplification, cloning, and analysis of serum virus.
Serum viral DNA was amplified by PCR before cloning, according to the
strategy previously described (8). Total viral DNA was
purified from serum by protease digestion and phenol extraction. Serum
(50 µl) was added to 200 µl of digestion buffer (10 mM Tris-HCl, pH
7.5, 1 mM EDTA, 0.2% sodium dodecyl sulfate) containing 500 mg of
pronase per ml. After 1 h at 37°C, the digested sample was extracted with an equal volume of phenol and the nucleic acids were
recovered by ethanol precipitation. The pellet was dissolved in water
and used for PCR amplification, using a primer pair that primed DNA
synthesis at positions corresponding to either end of the complete
minus-strand DNA. The primers used contained a SapI
recognition sequence (underlined) positioned such that cleavage of the
primers from the ends of the linear DNA would generate a full-length
linear copy of the DHBV genome that could be ligated at the
SapI "sticky" ends. The sequences of the primers used
were as follows: 5' CCC GCT CTT CA/G AAT TAC ACC CCT
CTC 3' (plus strand) and 5' CCC GCT CTT CA/T TCT
TAA GTT CCA CAT AGC CTA 3' (minus strand). Amplification was
carried out in a volume of 50 µl of standard PCR buffer, using 2.5 U
of Taq I DNA polymerase (Sigma) and 0.5 U of Pwo
DNA polymerase (Boehringer-Mannheim). The amplification reaction was
carried out for 35 cycles of 94°C for 5 s and 68°C for 4 min.
In subsequent reactions the denaturation time was extended to 15 s
and annealing was extended to 45 s at 58°C, with elongation for
4 min at 72°C to increase sensitivity.
The amplified linear DNA was purified by low-melting-temperature
agarose gel electrophoresis to remove excess primers and
then cleaved
by
SapI.
SapI recognition was provided by the
underlined
sequence, resulting in cleavage at 1 and 4 nucleotides
downstream
to leave a 3-nucleotide protruding 5' end. The
SapI-cleaved DNA
was repurified through a second
low-melting-temperature agarose
gel and then religated to produce
head-to-tail multimers, which
were cleaved by
EcoRI to
produce monomers.
EcoRI-linearized DNA
was cloned initially
in pSP65 as monomers, which were then isolated
and recloned as dimers
in
pSP65.
Plasmids containing DHBV dimer inserts were purified through CsCl
gradients containing ethidium bromide and used to transfect
LMH cells
(
14), as previously described (
5). Enveloped
virus
in the supernatant fluid was isolated by the DNase I-pronase
method
(
15), and the virus yield was determined by blot
hybridization,
or the genotype was determined by PCR and direct
sequencing.
Calculation of the relative growth rate of mutant 2619A during
spread of infection.
The rate of increase in the enrichment
(E) of wild-type virus (WT) relative to 2619A (Mut) was
determined experimentally to be 0.30 log10E per
24 h (Fig. 2). Enrichment of
wild-type virus between two points in time, t = t1 and t = t2, is defined as follows: E = [WT(t2)/Mut(t2)]/[WT(t1)/Mut(t1)]
or E = [WT(t2)/WT(t1)/[Mut(t2)/Mut(t1)]. If the replication rates of WT and Mut viruses are determined by the
first-order rate constants, kWT and
kMut, respectively, then E = exp(kWT ·
t)/exp(kMut ·
t). The following equation gives the relative growth rate
of the 2619A virus:
kMut/kWT = 1
(1/kWT) · (1nE)/
t = 1
(1/kWT) · 0.69, where
(log10E)/
t = 0.30 day
1 or (1nE)/
t = 0.69 day
1. For a doubling time of 9.4 h (0.39 days)
during the spread of wild-type DHBV in ducklings (12),
kWT is equal to (1n2)/0.39, or 1.77 day
1. Similarly, for a doubling time of 16 h
(13), kWT is equal to 1.03 day
1. Using these two estimates of
kWT, we calculated the relative growth rate of
2619A virus to be between 61 and 37% of that of the wild type.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
Enrichment of wild-type (wt) virus during spread of
infection. The ratio of wild-type virus to 2619A virus at peak viremia
was divided by the ratio of wild type to 2619A in the inoculum to
obtain the enrichment, E. The logarithm of E
(log10E) was plotted against the time at which
peak viremia occurred, and a linear regression curve was calculated.
The slope of the curve was determined to be 0.30 log10E per day, i.e., wild-type virus was
enriched over the 2619A virus approximately twofold each day
during the spread of infection until peak viremia.
|
|
 |
RESULTS |
A series of mutant DHBV genomes defective in the production of the
precore protein were constructed and tested for the ability to
replicate after transfection into LMH cells, infection of primary duck
hepatocytes, or inoculation into newly hatched ducklings (44a). One mutant, 2619A, was partially defective in
replication yet able to establish a chronic infection in vivo. This
mutant was selected for the present study. The purpose of this study was to determine how the relative replication rates of two viruses influence their selection in a chronic infection. For this purpose we
established a mixed infection with two competing virus strains and
measured the rate of replacement of the slower-replicating strain. As
the faster-replicating virus, we used the parent DHBV 16, which was
wild type for precore production.
Competition of wild type and 2619A during spread of infection and
measurement of replication defect.
Thirty ducklings were
inoculated at 3 days of age with a dose of either 106,
107, or 108 viral genomes containing a mixture
of wild-type and 2619A virus in ratios of 1:5, 1:50, or 1:500. Infected
ducklings were bled daily after infection until peak viremia was
reached and weekly thereafter. The viral DNA titers and the genotype of
virus in the blood were determined. Twenty-four birds developed a
viremia which peaked within 4 to 12 days postinoculation, and a mixed infection was detected in 19 of these (the lower detection limit for a
genotype was about 5% of the total). All of the birds showed enrichment of the wild-type virus compared with the inoculum. The
virological data for the group of 19 ducks with mixed infection are
presented in Table 1.
Enrichment of the wild-type virus indicated that the wild-type virus
replicated more rapidly than the competing mutant virus,
2619A.
Enrichment of the wild-type virus would be expected to
increase
according to the amount of growth of the two viruses
required to
achieve peak viremia. Therefore, more enrichment should
occur with
smaller inocula; however, we found that the time that
elapsed between
inoculation and peak viremia was a better predictor
of enrichment than
the size of the inoculum. As can be seen in
Fig.
2, the logarithm of
the enrichment,
E (expressed as the ratio
of wild type to
mutant at peak viremia divided by the ratio in
the inoculum), was
linearly proportional to the time required
to achieve peak viremia,
suggesting that the effective inoculum
size, as opposed to the amount
of virus injected, varied among
the individual birds. The slope of the
regression curve for this
plot was determined to be 0.30 log
E/day. Using the data of Jilbert
et al. (
12,
13)
showing that the doubling time of DHBV in
ducklings inoculated under
similar conditions was 9.4 to 16 h,
it was calculated that growth
rates for 2619A of 61 and 37% that
of wild-type virus, respectively,
would produce the observed amount
of wild-type enrichment (see
Materials and Methods). These data
confirm the presence of a
replication defect in mutant virus
2619A.
Changes in the ratio of genotypes during follow-up.
A group of
10 ducklings with mixed, predominantly 2619A, infections were selected
for follow-up studies to determine the rate of replacement of the
mutant by the wild-type virus. Assays for viral DNA in the blood, the
results of which are presented in Table
2, showed that this group of ducks
remained persistently infected during the course of the experiment.
Viremia was characterized by an initial peak followed by a rapid
decrease in viral-DNA-containing particles in the blood, which
eventually stabilized at levels 1 to 3 orders of magnitude below the
initial peak. This pattern has been previously reported in experimental
infections of ducklings (11, 17, 18).
The region of viral DNA containing the mutation was amplified from each
serum sample by PCR and subjected to direct sequencing
to determine the
ratio of wild type to 2619A in the serum virus.
Examples of the data
for two birds showing different enrichment
patterns are shown in Fig.
3. Serum samples from bird 40 showed
a
steady enrichment of the wild-type genotype during the course
of the
experiment, until the precore mutant virus was no longer
detected. This
result was expected, since the wild-type virus
replicated faster than
the precore mutant. In contrast, the genotype
of serum virus for bird
14 was initially enriched for the wild
type (days 8, 19, and 41), but
the pattern of enrichment was reversed
at later times (days 61 and 68),
and the precore mutant eventually
replaced the wild-type virus.

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 3.
Examples of two different patterns of selection during
chronic infection. The results of PCR sequencing assays for serum
samples obtained at various times postinfection are shown for two
ducklings. In the upper panels (bird 40), the wild type (WT)-specific
band is seen to increase continuously during chronic infection, while
in the lower set of panels (bird 14) the initial enrichment of wild
type is followed by replacement with the 2619A-specific band.
|
|
The data for 8 of the 10 birds followed are shown in Fig.
4A. Four ducklings with 17 to 50%
wild-type virus in the blood at
peak viremia, the start of the
follow-up samples, showed a continuous,
gradual enrichment in wild-type
virus until day 47 postinfection,
at which time the wild-type genotype
made up 91 to 100% of the
viral DNA (Fig.
4A, left graph). Because
further increases in
the ratios of wild-type virus to mutant virus
could not be accurately
calculated beyond this point, the follow-up
study on these four
birds was terminated. In a second group of four
ducklings the
proportion of wild-type virus showed a sustained decrease
or disappearance
following an initial increase (Fig.
4A, right graph).
In two ducklings,
birds 13 and 16, the wild-type genotype increased
slowly, with
intermittent periods of decrease (not shown).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 4.
Analysis of serum genotype and anti-core antibody titers
during chronic mixed infection. The separate graphs show the results
for four birds in which continuous enrichment of wild-type virus was
observed (wt enrichment) and four birds in which wild-type virus was
replaced by the 2619A virus (wt replacement). (A) The fraction of
wild-type virus in the serum, determined by PCR sequencing assay, was
plotted against the time postinfection. (B) The anti-core antibody
titers for the two birds shown in panel A, normalized to a standard
anti-core duck serum, were plotted against the time postinfection.
Symbols are used to represent results from the same individual birds in
panels A and B as follows. Left-hand graphs: x, bird 11; , bird 30;
, bird 40; , bird 41. Right-hand graphs: x, bird 8; , bird 10;
, bird 14; , bird 34.
|
|
Rate of wild-type virus enrichment during chronic infection.
In birds in which wild-type virus eventually became the dominant
genotype, the rate of enrichment was much lower after the liver was
fully infected than during the spread of infection. In order to
calculate an average enrichment rate (E/
t)
during this phase of the infection, we used the serum genotype data
obtained for birds 11, 30, 40, and 41 from the time of peak viremia
through 47 days postinfection to calculate the enrichment
(E) for wild-type virus (see Materials and Methods). The
log10E values were plotted against time
postinfection to obtain the graph shown in Fig.
5. As with the enrichment during the
spread of infection (Fig. 2), the increase in logE was
roughly linear over time, and a linear regression curve was calculated.
The slope of the regression, log10E/
t, was determined to be
0.035 log10E/
t, or approximately 0.12 times that calculated for the enrichment during the spread of
infection.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
Enrichment of wild-type virus during chronic infection.
The ratios of wild-type virus to 2619A virus in the serum of ducks 11, 30, 40, and 41 on days 6 through 47 were determined and used to
calculate the enrichment, E, over the earliest time point
(day 6 for birds 11 and 40 and day 7 for birds 30 and 41). The linear
regression was calculated for the combined data for all four birds.
|
|
Anti-core antibody response in birds with predominant wild-type or
2619A virus.
The selection against wild-type virus in four birds
(birds 8, 10, 14, and 34) did not obviously correlate with the any
virological parameters of the individual birds shown in Tables 1 and 2, including viremia, body weight (not shown), dose of infection, or size
of the inoculum. All birds showing selection against wild-type virus
were infected with inocula containing ratios of wild type to 2619A of
1:50 or less, but the importance of this correlation is uncertain.
Since the wild-type virus expressed precore protein and the 2619A virus
did not, it was possible that precore production formed the basis for a
selection against wild-type virus that differed among individual birds.
Such a selection could be mediated by the individual immunological
response of each infected bird. As an initial indicator of the
immunological response against precore and core epitopes we measured
the titers of total anti-core antibody of the eight individual birds
represented in Fig. 4A at various times postinfection. The results of
these assays are shown in the corresponding graphs of Fig. 4B.
Differences between the two groups of birds showing different patterns
of strain selection could be seen. Selection against
wild-type virus
was correlated with elevated levels of anticore
antibody that increased
throughout the follow-up period. Anti-core
antibody titers in the group
of birds showing no selection against
wild-type virus were more
variable, differing by more than 2 orders
of magnitude within the
group. In three of four birds, anti-core
antibody titers were stable or
decreased 10-fold or more from
an early peak value. These results
suggest that the immunological
response to precore and core epitopes
differed substantially among
individual birds in a manner that could be
related to the relative
enrichment of the two
strains.
Analysis of the replication properties of the predominant 2619A
strain in birds 8, 12, 14, and 34.
It was possible that chronic
infection selected for a virus that replicated more rapidly than either
the wild-type or the 2619A virus in the original inoculum and which
eventually replaced both of the infecting strains. This replacement
would appear in our assay as an enrichment of either wild-type or 2619A
virus, depending on which genetic marker was carried by the variant at position 2619. If this were the case, viruses carrying the 2619A mutation predominating at late times postinfection in birds 8, 10, 14, and 34 would show a replication rate that was enhanced over that of
wild-type virus. In order to measure the growth properties of these
viruses, viral genomes from birds showing the presence of only the
2619A mutant, i.e., birds 8, 14, and 34, were amplified from serum
obtained at 77 days postinfection, using the strategy devised for
high-fidelity PCR of complete hepadnavirus genomes (8). In
addition, serum DNA obtained at 77 days from bird 12, which never
showed detectable wild-type virus (not shown), was also amplified. Two
viral genomes from each amplified sample were cloned as head-to-tail
dimers in plasmid pSP65. The cloned viral genomes were then compared
with wild-type genomes for their relative rates of replication in LMH
cells and in ducklings.
Of the 10 genomes that were cloned and tested, 9 clones were able to
produce enveloped virus after transfection into LMH cells
(data not
shown). If these 2619A genomes were selected in vivo
because they had
acquired the ability to replicate faster than
wild-type virus, we
should observe their enrichment during competition
with wild-type virus
either in vitro or in vivo. To test this
prediction, eight 2619A dimer
clones were cotransfected with a
wild-type dimer clone into LMH cells
at a ratio of 1:1, and the
virus produced in the medium was injected
into 3-day-old ducklings.
The ratios of wild-type genomes to 2619A
genomes in the plasmid
mixture, in virus from the culture medium, and
in virus from the
serum of the infected ducklings at peak viremia were
compared
by PCR and sequencing. Examples of these assays are presented
in Fig.
6, and the combined results of
all the assays on these
clones are shown in Table
3. We observed that all 2619A clones
retained a replication defect in LMH cells that was comparable
to that
of the 2619A parent in the original inoculum. Neither
the authentic
2619A mutant nor any of the cloned genomes were
detected in the serum
after passage in ducklings, consistent with
the high level of
enrichment of wild-type virus shown in Fig.
2. This result indicates
that the wild-type virus was not replaced
by a faster-replicating
variant of the precore mutant.

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 6.
PCR sequencing assay for the relative replication of
2619A clones obtained from serum. Whole DHBV genomes were amplified and
cloned from the sera of birds 8, 12, 14, and 34 obtained at day 77 postinfection. The genomes were subcloned as dimers in pSP65 and
cotransfected with a wild-type (wt) DHBV plasmid into LMH cells, and
the supernatants were used to infect ducklings (107 viral
genomes per duckling). PCR sequencing was performed on the original
plasmid mixture (plasmid), on DNA from enveloped virus from the
supernatants of the transfected cells (virus), and on viral DNA from
serum of the infected ducklings (serum). The yield of mutant viruses
(m) in the culture supernatants was used to calculate the replication
rate of the mutant relative to that of the wild type (WT) (right).
Mutant virus was not detected in serum from any of the mixed infections
of ducklings.
|
|
 |
DISCUSSION |
The results of our experiments suggest that selection between two
competing strains of DHBV during the chronic phase of an infection is
not necessarily determined by the relative replication rates of the two
strains. We have examined the behavior of two strains of DHBV with
different replication rates during mixed infections lasting up to 12 weeks postinfection. During the initial stage, in which infection
spread throughout the liver, strain selection was always determined by
the relative growth rates of the two viruses. The evidence for this
conclusion was the fact that the faster-replicating wild-type virus was
always highly enriched, and the extent of enrichment was proportional
to the amount of growth that preceded peak viremia (Fig. 2). The
replication rate of the precore mutant, 2619A, was estimated to be 37 and 61% of that of the wild-type virus based on the data from this study combined with two previously estimated replication rates for
wild-type virus in ducklings (12, 13). This range was inclusive of the relative replication rates of the parental 2619A genome calculated in transfected LMH cells, i.e., 54 to 58% of that of
the wild type (Table 3), and differences in the estimates can probably
be attributed to a combination of various experimental errors and
assumptions. In any case, the replication rate appeared to be the
overriding factor in strain selection of DHBV when replication was not
limited by the number of susceptible cells, i.e., during the spread of infection.
Strain selection during the chronic phase of infection, when all
hepatocytes were infected, differed in two respects from that observed
during the spread of infection. In 4 of 10 birds, wild-type virus
continued to be enriched, but at a greatly reduced rate. While
enrichment occurred at the rate of 0.3 log10E
day
1 (Fig. 2) during the spread of infection, the rate of
enrichment during chronic infection was around 0.035 ln10E day
1 (Fig. 5). This result
may be a reflection of the dynamic state of the infection after the
liver is fully infected. That is, continued competition between the two
virus strains may be limited by the rate at which newly susceptible
cells appear in the liver or by the rate at which covalently closed
circular DNA molecules in cells that are already infected are replaced
by newly synthesized molecules. In these circumstances, the rate of
enrichment can be used to calculate the dynamic state of the infection
in vivo (44b).
In a second group of four birds, strain selection was determined by
factors not directly related to replication rate. In these birds the
faster-replicating wild-type virus was replaced by the precore mutant
despite its slower replication rate. This result indicates that a
selective advantage of the mutant virus was expressed that was
sufficient to overcome its replication disadvantage. Replacement of the
wild-type virus by the 2619A virus in these birds was correlated with
elevated titers of anti-core antibody. The reason for differences in
the anti-core antibody titers is not known, but we can suggest three
possibilities that are not mutually exclusive. First, the anti-core
antibody titers in birds producing higher levels of e antigen might be
reduced correspondingly by titration with cross-reacting soluble e
antigen in the blood. Thus, birds with high production of e antigen
from wild-type virus would have lower levels of anti-core and anti-e
antibody. The natural responses of DHBV-infected ducks to core and e
antigens and the cross-reactivity of these antigens have not been
characterized, and therefore it is difficult to evaluate this
explanation. Alternatively, the anti-core antibody response might be a
reflection of the level of antigen stimulation caused by release of
viral cores from injured hepatocytes. Hepatocyte injury could be part
of the mechanism of selection against wild-type virus in favor of the
precore mutant. Thus, higher anti-core antibody titers would be found
in birds in which wild-type virus was being replaced by the precore
mutant. Finally, the anti-core antibody-specific B-cell response could reflect the strength or quality of the Th response, which in turn would
influence the T-cell-mediated immune pressure on infected cells in the
liver. In this scenario, the wild-type virus would be more sensitive to
the cellular immune response in the liver than the precore-minus mutant.
The mechanism for a putative immunological selection against wild-type
virus in favor of our precore mutant is not known. Presumably, such a
selection would operate at the level of the infected cell, since the
precore protein is not incorporated into virus particles. The core and
precore proteins of HBV are generally considered to be antigenically
identical at the T-cell level, but it is possible that (i) the precore
region may encode one or more unique T-cell epitopes or (ii) part of
the precore protein is proteolytically processed to produce peptides
that are recognized by unique precore-specific T-cell receptors on lymphocytes.
Alternatively, immunological selection might depend on the growth
properties of the 2619A mutant. Precore variants have been widely
observed to emerge during chronic HBV infections, leading to the
speculation that such variants have been selected on the basis of an
enhanced rate of replication. This explanation does not appear to apply
in our experiments, since the precore mutant selected in vivo
replicated more slowly than the wild type when subjected to a second
passage in vitro and in vivo. In fact, it is possible that strain
selection in our experiment might have depended on the reduced
replication rate of the 2619A mutant if, for example, the cellular
immune response were able to distinguish relatively small differences
in replication rate as the basis for immune pressure. In humans, the
emergence of precore variants of HBV is often associated with
exacerbations of liver disease, consistent with an immunological
selection against wild-type virus-infected cells. This hypothesis would
imply that the emergence of precore variants may be determined by
selective pressures that are associated with the disease and that the
disease itself is not an inherent property of precore-minus variants.
Finally, it is possible that precore expression or wild-type
replication is toxic in some animals for reasons unrelated to the
immune response. This hypothesis does not depend on an immunological selection occurring, but toxicity of wild-type replication may produce
higher levels of anti-core antibody from greater antigenic stimulation
by cores released from dying hepatocytes. Individual differences among
birds could be related to differences in their genetic
backgrounds, for example.
It is commonly assumed that expression of the precore protein results
in some benefit to DHBV during some stage of its life cycle. These
studies do not contradict this view; they indicate, however, that
precore protein may be disadvantageous to the virus under some
conditions. In fact, if the precore protein or e antigens act at a very
early phase of infection to influence the course of the immune
response, this influence may not have been exerted in our experiments
because the inoculum contained a large excess of precore-minus virus.
Thus, it is possible that the positive function of the precore protein
in hepadnaviruses may be expressed only during a limited window in the
viral life cycle.
 |
ACKNOWLEDGMENTS |
We express appreciation to Andrew Kuhn, Josh Ramey, and Bai-Hua
Zhang for technical assistance and to Wengang Yang, Raymond Lenhoff,
and Carolyn Luscombe for helpful suggestions and advice during the
course of these experiments. We thank W. S. Mason for helpful
advice on the manuscript.
This work was supported by HSS grant CA-42542.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Genetics and Microbiology, The University of New Mexico
School of Medicine, Albuquerque, NM 87131. Phone and Fax: (505)
272-8896. E-mail: jsummer{at}unm.edu.
 |
REFERENCES |
| 1.
|
Baumert, T. F.,
A. Marrone,
J. Vergalla, and T. J. Liang.
1998.
Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression.
J. Virol.
72:6785-6795[Abstract/Free Full Text].
|
| 2.
|
Bonino, F.,
F. Rosina,
M. Rizzetto,
R. Rizzi,
E. Chiaberge,
R. Tardanico,
F. Callea, and G. Verme.
1986.
Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
Gastroenterology
90:1268-1273[Medline].
|
| 3.
|
Carman, W.,
M. R. Jacyna,
S. Hadziyannis,
P. Karayiannis,
M. J. McGarvey,
A. Makris, and H. C. Thomas.
1989.
Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.
Lancet
ii:588-591.
|
| 4.
|
Chen, H. S.,
M. C. Kew,
W. E. Hornbuckle,
B. C. Tennant,
P. J. Cote,
J. L. Gerin,
R. H. Purcell, and R. H. Miller.
1992.
The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host.
J. Virol.
66:5682-5684[Abstract/Free Full Text].
|
| 5.
|
Condreay, L.,
C. Aldrich,
L. Coates,
W. S. Mason, and T.-T. Wu.
1990.
Efficient duck hepatitis B virus production by an avian tumor cell line.
J. Virol.
64:3249-3258[Abstract/Free Full Text].
|
| 6.
|
Dane, D. S.,
C. H. Cameron, and M. Briggs.
1970.
Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.
Lancet
i:695-698.
|
| 7.
|
Ganem, D.
1996.
Hepadnaviridae and their replication, p. 2703-2737.
In
B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 8.
|
Gunther, S.,
B. C. Li,
S. Miska,
D. H. Kruger,
H. Meisel, and H. A. Will.
1995.
A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients.
J. Virol.
69:5437-5444[Abstract].
|
| 9.
|
Huang, M., and J. Summers.
1991.
Infection initiated by the RNA pregenome of a DNA virus.
J. Virol.
65:5435-5439[Abstract/Free Full Text].
|
| 10.
|
Jean-Jean, O.,
M. Levrero,
H. Will,
M. Perricaudet, and J. M. Rossignol.
1989.
Expression mechanism of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigen.
Virology
170:99-106[Medline].
|
| 11.
|
Jilbert, A. R.,
J. A. Botten,
D. S. Miller,
E. M. Bertram,
P. M. Hall,
J. Kotlarski, and C. J. Burrell.
1998.
Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
Virology
244:273-282[Medline].
|
| 12.
|
Jilbert, A. R.,
J. S. Freiman,
C. J. Burrell,
M. Holmes,
E. J. Gowans,
R. Rowland,
P. Hall, and Y. E. Cossart.
1988.
Virus-liver cell interactions in duck hepatitis B virus infection. A study of virus dissemination within the liver.
Gastroenterology
95:1375-1382[Medline].
|
| 13.
|
Jilbert, A. R.,
D. S. Miller,
C. A. Scougall,
H. Turnbull, and C. J. Burrell.
1996.
Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks.
Virology
226:338-345[Medline].
|
| 14.
|
Kawaguchi, T.,
K. Nomura,
Y. Hirayama, and T. Kitagawa.
1987.
Establishment and characterization of a chicken hepatocellular carcinoma cell line LMH.
Cancer Res.
47:4460-4464[Abstract/Free Full Text].
|
| 15.
|
Lenhoff, R., and J. Summers.
1994.
Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes.
J. Virol.
68:5706-5713[Abstract/Free Full Text].
|
| 16.
|
Lenhoff, R., and J. Summers.
1994.
Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus.
J. Virol.
68:4565-4571[Abstract/Free Full Text].
|
| 17.
| Lenhoff, R., C. A. Luscombe, and J. Summers.
Acute liver injury following infection with a cytopathic strain of duck
hepatitis B virus. Hepatology, in press.
|
| 18.
| Lenhoff, R. L., C. A. Luscombe, and J. Summers. Competition in vivo between a cytopathic variant and a
wild type duck hepatitis B virus. Virology, in press.
|
| 19.
|
Li, D. H.,
J. E. Newbold, and J. M. Cullen.
1996.
Natural populations of woodchuck hepatitis virus contain variant precore and core sequences including a premature stop codon in the epsilon motif.
Virology
220:256-262[Medline].
|
| 20.
|
Magnius, L. O., and J. A. Espmark.
1972.
New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.
J. Immunol.
109:1017-1021[Abstract/Free Full Text].
|
| 21.
|
Mandart, E.,
A. Kay, and F. Galibert.
1984.
Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences.
J. Virol.
49:782-792[Abstract/Free Full Text].
|
| 22.
|
Marion, P. L.,
L. S. Oshiro,
D. C. Regnery,
G. H. Scullard, and W. S. Robinson.
1980.
A virus in Beechey ground squirrels that is related to hepatitis B virus of humans.
Proc. Natl. Acad. Sci. USA
77:2941-2945[Abstract/Free Full Text].
|
| 23.
|
Mason, W. S.,
C. Aldrich,
J. Summers, and J. M. Taylor.
1982.
Asymmetric replication of duck hepatitis B virus DNA in liver cells (free minus strand DNA).
Proc. Natl. Acad. Sci. USA
79:3997-4001[Abstract/Free Full Text].
|
| 24.
|
Mason, W. S.,
G. Seal, and J. Summers.
1980.
A virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus.
J. Virol.
36:829-836[Abstract/Free Full Text].
|
| 25.
|
Milich, D. R.
1997.
Influence of T-helper cell subsets and crossregulation in hepatitis B virus infection.
J. Viral Hepat.
4(Suppl. 2):48-59.
|
| 26.
|
Milich, D. R.,
M. K. Chen,
J. L. Hughes, and T. E. Jones.
1998.
The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence.
J. Immunol.
160:2013-2021[Abstract/Free Full Text].
|
| 27.
|
Milich, D. R.,
F. Schodel,
J. L. Hughes,
J. E. Jones, and D. L. Peterson.
1997.
The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.
J. Virol.
71:2192-2201[Abstract].
|
| 28.
|
Moriyama, K.,
H. Okamoto,
F. Tsuda, and M. Mayumi.
1996.
Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.
Virology
226:269-280[Medline].
|
| 29.
|
Nassal, M., and H. Schaller.
1996.
Hepatitis B virus replication an update.
J. Viral Hepat.
3:217-226[Medline].
|
| 30.
|
Pult, I.,
T. Chouard,
S. Wieland,
R. Klemenz,
M. Yaniv, and H. E. Blum.
1997.
A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis B.
Hepatology
25:1507-1515[Medline].
|
| 31.
|
Raimondo, G.,
M. Stemler,
R. Schneider,
G. Wildner,
G. Squadrito, and H. Will.
1990.
Latency and reactivation of a precore mutant hepatitis B virus in a chronically infected patient.
J. Hepatol.
11:374-380[Medline].
|
| 32.
|
Robinson, W. S.,
D. A. Clayton, and R. L. Greenman.
1974.
DNA of a human hepatitis B virus candidate.
J. Virol.
14:384-391[Abstract/Free Full Text].
|
| 33.
|
Scaglioni, P. P.,
Melegari, and J. R. Wands.
1997.
Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame.
Virology
233:374-381[Medline].
|
| 34.
|
Schlicht, H. J.,
J. Salfeld, and H. Schaller.
1987.
The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation.
J. Virol.
61:3701-3709[Abstract/Free Full Text].
|
| 35.
|
Seeger, C.,
D. Ganem, and H. E. Varmus.
1986.
Biochemical and genetic evidence for the hepatitis B virus replication strategy.
Science
232:477-484[Abstract/Free Full Text].
|
| 36.
|
Sprengel, R.,
E. F. Kaleta, and H. Will.
1988.
Isolation and characterization of a hepatitis B virus endemic in herons.
J. Virol.
62:3832-3839[Abstract/Free Full Text].
|
| 37.
|
Standring, D. N.,
J. H. Ou,
F. R. Masiarz, and W. J. Rutter.
1988.
A signal peptide encoded within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens in Xenopus oocytes.
Proc. Natl. Acad. Sci. USA
85:8405-8409[Abstract/Free Full Text].
|
| 38.
|
Summers, J., and W. S. Mason.
1982.
Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate.
Cell
29:403-415[Medline].
|
| 39.
|
Summers, J.,
A. P. O'Connell, and I. Millman.
1975.
Genome of hepatitis B virus: restriction enzyme cleavage and structure of the DNA extracted from Dane particles.
Proc. Natl. Acad. Sci. USA
72:4597-4601[Abstract/Free Full Text].
|
| 40.
|
Summers, J.,
P. Smith,
M. Huang, and M. Yu.
1991.
Regulatory and morphogenetic effects of mutations in the envelope proteins of an avian hepadnavirus.
J. Virol.
65:1310-1317[Abstract/Free Full Text].
|
| 41.
|
Summers, J.,
J. M. Smolec, and R. L. Snyder.
1978.
A virus similar to hepatitis B virus associated with hepatitis and hepatoma in woodchucks.
Proc. Natl. Acad. Sci. USA
75:4533-4537[Abstract/Free Full Text].
|
| 42.
|
Testut, P.,
C. A. Renard,
O. Terradillos,
L. Vitvitski-Trepo,
F. Tekaia,
C. Degott,
J. Blake,
B. Boyer, and M. A. Buendia.
1996.
A new hepadnavirus endemic in arctic ground squirrels in Alaska.
J. Virol.
70:4210-4219[Abstract].
|
| 43.
|
Thomas, H. C.
1995.
The emergence of envelope and precore/core variants of hepatitis B virus: the potential role of antibody selection.
J. Hepatol.
22:1-8[Medline].
|
| 44.
|
Trepo, C.,
F. Zoulim,
C. Alonso,
M. A. Petit,
C. Pichoud, and L. Vitvitski.
1993.
Diagnostic markers of viral hepatitis B and C.
Gut
34:S20-S25.
|
| 44a.
| Yang, W., and J. Summers. Unpublished data.
|
| 44b.
| Zhang, Y.-Y., and J. Summers. Unpublished
data.
|
| 45.
|
Zoulim, F.,
J. Saputelli, and C. Seeger.
1994.
Woodchuck hepatitis virus X protein is required for viral infection in vivo.
J. Virol.
68:2026-2030[Abstract/Free Full Text].
|
Journal of Virology, May 1999, p. 3616-3622, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Frelin, L., Wahlstrom, T., Tucker, A. E., Jones, J., Hughes, J., Lee, B. O., Billaud, J.-N., Peters, C., Whitacre, D., Peterson, D., Milich, D. R.
(2009). A Mechanism To Explain the Selection of the Hepatitis e Antigen-Negative Mutant during Chronic Hepatitis B Virus Infection. J. Virol.
83: 1379-1392
[Abstract]
[Full Text]
-
Cao, F., Scougall, C. A., Jilbert, A. R., Tavis, J. E.
(2009). Pre-P Is a Secreted Glycoprotein Encoded as an N-Terminal Extension of the Duck Hepatitis B Virus Polymerase Gene. J. Virol.
83: 1368-1378
[Abstract]
[Full Text]
-
Maenz, C., Loscher, C., Iwanski, A., Bruns, M.
(2008). Inhibition of duck hepatitis B virus infection of liver cells by combined treatment with viral e antigen and carbohydrates. J. Gen. Virol.
89: 3016-3026
[Abstract]
[Full Text]
-
Guarnieri, M., Kim, K.-H., Bang, G., Li, J., Zhou, Y., Tang, X., Wands, J., Tong, S.
(2006). Point Mutations Upstream of Hepatitis B Virus Core Gene Affect DNA Replication at the Step of Core Protein Expression. J. Virol.
80: 587-595
[Abstract]
[Full Text]
-
Walters, K.-A., Joyce, M. A., Addison, W. R., Fischer, K. P., Tyrrell, D. L. J.
(2004). Superinfection Exclusion in Duck Hepatitis B Virus Infection Is Mediated by the Large Surface Antigen. J. Virol.
78: 7925-7937
[Abstract]
[Full Text]
-
Zhang, Y.-Y., Summers, J.
(2000). Low Dynamic State of Viral Competition in a Chronic Avian Hepadnavirus Infection. J. Virol.
74: 5257-5265
[Abstract]
[Full Text]
-
Seeger, C., Mason, W. S.
(2000). Hepatitis B Virus Biology. Microbiol. Mol. Biol. Rev.
64: 51-68
[Abstract]
[Full Text]